Neuromyelitis optica - an update: 2007-2009.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 2824950)

Published in Ann Indian Acad Neurol on October 01, 2009

Authors

Anu Jacob1

Author Affiliations

1: The Walton Centre for Neurology and Neurosurgery, Liverpool, L97LJ, United Kingdom.

Articles cited by this

Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (2004) 13.18

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med (2005) 10.39

The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03

Brain abnormalities in neuromyelitis optica. Arch Neurol (2006) 4.28

Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol (2008) 3.95

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology (2009) 3.43

NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology (2008) 3.21

An open label study of the effects of rituximab in neuromyelitis optica. Neurology (2005) 2.99

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain (2008) 2.96

Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol (2006) 2.80

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69

The molecular basis of water transport in the brain. Nat Rev Neurosci (2003) 2.66

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol (2008) 2.58

Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology (2002) 2.41

Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology (2007) 2.32

Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med (2008) 2.26

CNS aquaporin-4 autoimmunity in children. Neurology (2008) 2.10

Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Glia (2009) 1.93

Water movements in the brain: role of aquaporins. Trends Neurosci (2007) 1.81

An approach to the diagnosis of acute transverse myelitis. Semin Neurol (2008) 1.80

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J (2008) 1.61

Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol (2008) 1.59

Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. J Immunol (2008) 1.58

Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates. Arch Neurol (2008) 1.55

Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology (1998) 1.53

Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology (2009) 1.52

Altered blood-brain barrier integrity in adult aquaporin-4 knockout mice. Neuroreport (2008) 1.40

Neuromyelitis optica: changing concepts. J Neuroimmunol (2007) 1.39

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler (2007) 1.37

Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study. Eur Radiol (2009) 1.31

An epidemiological study of neuromyelitis optica in Cuba. J Neurol (2009) 1.30

Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. Mult Scler (2009) 1.28

Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol (2009) 1.27

Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci (2008) 1.22

Optical coherence tomography in neuromyelitis optica. Arch Neurol (2008) 1.20

Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis. J Neurol Neurosurg Psychiatry (2009) 1.18

Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve (2009) 1.13

Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler (2007) 1.08

Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G. Ann Neurol (2008) 0.98

Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult Scler (2007) 0.96

Neuromyelitis optica and asian phenotype of multiple sclerosis. Ann N Y Acad Sci (2008) 0.95

Transverse myelitis spectrum disorders. Neurol India (2009) 0.95

Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica. Autoimmun Rev (2009) 0.93

[Optic neuromyelitis and bilateral acute retinal necrosis due to varicella zoster in a patient with AIDS]. J Fr Ophtalmol (1998) 0.89

Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays. Neurology (2006) 0.88

Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry (2007) 0.88

Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis. Mult Scler (2008) 0.87

White matter spectroscopy in neuromyelitis optica: a case control study. J Neurol (2009) 0.82

Seronegative neuromyelitis optica: improvement following lymphocytapheresis treatment. Mult Scler (2008) 0.82

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4. J Neurol Neurosurg Psychiatry (2008) 0.80

[Severe bouts of neuromyelitis optica: dramatic improvement after plasma exchanges]. Rev Neurol (Paris) (2008) 0.78

To test or not to test: NMO-IgG and optic neuritis. Neurology (2008) 0.77

Prevention of orthogonal array of particles formation as a treatment approach for neuromyelitis optica. Med Hypotheses (2009) 0.77

A case of neuromyelitis optica with gadolinium-enhancing brain lesions and Parinaud syndrome. Arch Neurol (2009) 0.76